Horizon Therapeutics Publ... (HZNP)
116.30
0.00 (0.00%)
At close: Jan 16, 2025, 9:00 PM
0.00% (1D)
| Bid | n/a |
| Market Cap | 26.6B |
| Revenue (ttm) | 3.64B |
| Net Income (ttm) | 438M |
| EPS (ttm) | 1.88 |
| PE Ratio (ttm) | 61.861702127659576 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 23,917,757 |
| Avg. Volume (20D) | 23,917,757 |
| Open | 116.34 |
| Previous Close | 116.30 |
| Day's Range | 116.30 - 116.34 |
| 52-Week Range | 116.30 - 116.34 |
| Beta | 1.01 |
About HZNP
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Jul 28, 2011
Employees 2,190
Stock Exchange NASDAQ
Ticker Symbol HZNP